New Releases from NCBI BookshelfCapmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal).​Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal).